Answers are grounded in this paper and cite their sources.
Reveals associations of vitamin A status with anemia and iron levels in pregnant women, suggesting a role in improving maternal health.
Background and objectives: Vitamin A deficiency (VAD) is a public health challenge among pregnant women in low-and middle-income countries and has been linked to maternal anemia and adverse birth outcomes, such as preterm delivery, intrauterine growth restriction, and low birthweight (1,2) . In the Free State Province of South Africa, there is limited information on the vitamin A status of pregnant women and its link with birth outcomes. Hence, this study aimed to investigate the vitamin A intake and status of pregnant women in the Free State, as well as the associations between vitamin A status and anemia, iron status, and birth outcomes. Venous blood was taken cross-sectionally from 427 pregnant women to measure biomarkers of vitamin A status (retinol binding protein 4 (RBP4)), iron status (ferritin, soluble transferrin receptor), anaemia (hemoglobin (Hb)), and inflammation (C-reactive protein (CRP) and α1-acid glycoprotein (AGP)). Sociodemographic information, HIV exposure, birth outcomes (including birth weight and gestational age at birth), and dietary vitamin A intake data were collected using a structured questionnaire in a one-on-one interview. Plasma RBP4 and ferritin concentrations were adjusted for inflammation using the Thurnham correction method based on CRP >5 mg/L and AGP >1 g/L (3) . Multiple linear regression models were used to determine the association between vitamin A status and anaemia and iron status, as well as birth outcomes. Ferritin and soluble transferrin receptor concentrations were log-transformed in the regression model. Ethics approval was obtained from the University of the Free State Health Sciences Research Ethics Committee. At a median gestational age of 32 weeks, the median dietary intake of vitamin A was 1007 µg RAE/d, with 19% of participants having an intake below the estimated average requirement of 550 µg/d. Median (IQR) plasma RBP4 concentration was 1.66 (0.90) µmol/L, with 90.4% having adequate vitamin A status (i.e., RBP4 ≥ 1.05 µmol/L), while 8.7% were vitamin A insufficient (i.e., RBP4 < 0.7 - <1.05 µmol/L), and 0.9% were vitamin A deficient (i.e., RBP4 < 0.7 µmol/L). Hb and ferritin concentrations were higher among participants with adequate vitamin A compared to those with insufficient or deficient vitamin A levels (11.2±1.46g/dL, vs 10.7±1.69g/dL, p=0.033) and (23.2 (13.28, 40.53) μg/L, vs 18.5 (8.72, 28.46) μg/L, p=0.022), respectively. Plasma RBP4 was positively associated with Hb (β=0.360, 95%CI: 0.181-0.539, p <0.001) and ferritin (β=0.316, 95%CI: 0.096-0.536, p=0.005). No significant associations were observed between plasma RBP4 and soluble transferrin receptor, birth weight, or preterm birth. The prevalence of VAD was low in this sample of pregnant women. However, the positive association between plasma RBP4 and Hb as well as ferritin concentrations highlights the importance of adequate vitamin A status in preventing maternal anaemia and iron deficiency in pregnancy.
No takes yet. Share an insight, caveat, or question.
Carboo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: